On January 21, 2016, the Committee will discuss safety and effectiveness data, including challenge study endpoints, for licensure of food allergy immunotherapy products, and the clinical development of aeroallergen immunotherapy products for the prevention of respiratory allergic disease.
Back to All Events
Earlier Event: January 14
Vaccines and Related Biological Products Advisory Committee
Later Event: January 22
POSTPONED: Peripheral and Central Nervous Systems Drugs Advisory Committee